SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Idorsia DARI-DREAM Phase 3 Study to Randomize 344 Participants

The DARI-DREAM Phase 3 study will randomize 344 participants to QUVIVIQ 50 mg or placebo.

Related stories